Serum Angiotensin-Converting Enzyme in Patients Suffering from Multiple Sclerosis and Healthy Controls: a Pilot Study

  • N. Razazian
  • V. AlmasiEmail author
  • D. Afshari
  • A. Bostani
  • N. Moradian
  • M. Farahvashi

Considering that angiotensin-converting enzyme (ACE) plays an important role in the pathogenesis of multiple sclerosis (MS), while information on the levels of this enzyme in biological liquids is rather limited, the ACE levels in blood serum of 30 patients with clinically diagnosed MS and 30 healthy individuals of comparable ages were measured using an enzymatic method (Biorexfars Chemical kits). Mean serum ACE levels in patients and controls were 45.97 ± 18.95 and 44.40 ± 11.04 IU/l (means ± s.d.), respectively, and these values did not differ from each other significantly (P = 0.70). In four patients and one control subject, the ACE levels exceeded the normal range (8 to 65 IU/l). There were no significant gender-related differences in the ACE levels in both examined groups.


multiple sclerosis angiotensin-converting enzyme renin-angiotensin system 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E. Kingwell, J. J. Marriott, N. Jetté, et al., “Incidence and prevalence of multiple sclerosis in Europe: a systematic review,” BMC Neurol., 13, 128 (2013).CrossRefGoogle Scholar
  2. 2.
    Atlas: Multiple Sclerosis Resources in the World 2008, World Health Organization, Geneva (2008).Google Scholar
  3. 3.
    Atlas of MS 2013: Mapping Multiple Sclerosis around the World, Multiple Sclerosis International Federation, London (2013).Google Scholar
  4. 4.
    R. Tanasescu, C. Ionete, I. J. Chou, and C. S. Constantinescu, “Advances in the treatment of relapsing-remitting multiple sclerosis,” Biomed. J., 37, No. 2, 41-49 (2014).CrossRefGoogle Scholar
  5. 5.
    J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker, “Multiple sclerosis,” New Engl. J. Med., 343, No. 13, 938-952 (2000).CrossRefGoogle Scholar
  6. 6.
    K. Kolasa, “How much is the cost of multiple sclerosissystematic literature review,” Przegl. Epidemiol., 67, No. 1, 75-79, 157-160 (2013).Google Scholar
  7. 7.
    C. P. Kamm, B. M. Uitdehaag, and C. H. Polman, “Multiple sclerosis: current knowledge and future outlook,” Eur. Neurol., 72, Nos. 3/4, 132-141 (2014).Google Scholar
  8. 8.
    Z. Babaloo, M. R. Aliparasti, F. Babaiea, et al., “The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels,” Immunol. Lett., 164, No. 2, 76-80 (2015).CrossRefGoogle Scholar
  9. 9.
    M. Platten, S. Youssef, E. M. Hur, et al., “Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity,” Proc. Natl. Acad. Sci. USA, 106, No. 35, 14948-14953 (2009).CrossRefGoogle Scholar
  10. 10.
    J. Liu, P. Zhang, H. He, et al., “Losartan modulates T helper type 1 cells and T helper type 17 cells-mediated responses in a mouse model of lipopolysaccharideinduced acute lung injury,” Zhonghua. Nei Ke Za Zhi., 53, No. 10, 804-808 (2014).Google Scholar
  11. 11.
    J. Stegbauer, D. H. Lee, S. Seubert, et al., “Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system,” Proc. Natl. Acad. Sci. USA, 106, No. 35, 14942-14947 (2009).CrossRefGoogle Scholar
  12. 12.
    C. S. Constantinescu, D. B. Goodman, R. I. Grossman, et al., “Serum angiotensin-converting enzyme in multiple sclerosis,” Arch. Neurol., 54, No. 8, 1012-1015 (1997).CrossRefGoogle Scholar
  13. 13.
    M. Kawajiri, M. Mogi, N. Higaki, et al., “Angiotensinconverting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis,” Mult. Scler., 15, No. 2, 262-265 (2009).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • N. Razazian
    • 1
  • V. Almasi
    • 2
    Email author
  • D. Afshari
    • 1
  • A. Bostani
    • 1
  • N. Moradian
    • 1
  • M. Farahvashi
    • 3
  1. 1.Kermanshah University of Medical SciencesKermanshahIran
  2. 2.Students Research CommitteeKermanshah University of Medical SciencesKermanshahIran
  3. 3.Lorestan University of Medical SciencesKhorramabadIran

Personalised recommendations